Company profile: Artelon
1.1 - Company Overview
Company description
- Provider of bio-textile solutions for kinematic reinforcement of tendon and ligament reconstruction, developing synthetic materials for tissue reconstruction and restoring stability and motion. Products include FLEXBAND biomaterial and systems (Twist, Solo, Multi, FIX), FLEXBAND Plus, FLEXPATCH, Dynamic Matrix Technology used in over 60,000 implantations, and educational programs.
Products and services
- Dynamic Matrix Technology: Proprietary platform enhancing biological and mechanical soft tissue reconstruction, utilized in over 60,000 implantations worldwide to reinforce tendon and ligament kinematics
- FLEXBAND: Biointegrative biomaterial restoring natural strength and elasticity to healing soft tissues, integrating with the body and progressively replaced by new tissue over several years
- FLEXBAND Systems: Modular suite including Twist, Solo, Multi, and FIX, delivering procedure-specific tools and implants in sterile kits for targeted soft tissue reconstruction indications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Artelon
Regentys
HQ: United States
Website
- Description: Provider of early-stage regenerative medicine and innovative medical devices for gastrointestinal applications, including ECMH (Extracellular Matrix Hydrogel), a porcine-derived extracellular matrix hydrogel designed to create an environment favorable for new tissue growth to replace diseased or damaged tissue in the gastrointestinal tract.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regentys company profile →
Lamellar
HQ: United Kingdom
Website
- Description: Provider of novel healthcare products based on mimicry or modification of the lamellar body secretory system, leveraging Lamellasomes™ technology and associated intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lamellar company profile →
Lotus Tissue Repair
HQ: United States
Website
- Description: Provider of proprietary recombinant human collagen Type VII (rC7) technology for accelerating chronic wound healing in dermatologic conditions, including diabetic foot ulcers, venous stasis ulcers and similar conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lotus Tissue Repair company profile →
PolarityTE
HQ: United States
Website
- Description: Provider of SkinTE, an investigational product for complex chronic and acute wound treatment that uses a patient's own tissue to regenerate functional skin, and a clinical development program advancing SkinTE through clinical trials to obtain regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PolarityTE company profile →
Tepha
HQ: United States
Website
- Description: Provider of a new class of absorbable biomaterials for medical devices, developing and commercializing proprietary polyhydroxyalkanoate technology tailored to meet unmet needs across multiple fields and to be used in surgical procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tepha company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Artelon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Artelon
2.2 - Growth funds investing in similar companies to Artelon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Artelon
4.2 - Public trading comparable groups for Artelon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →